Products for Research Use Only
RegisterLogin

Tat-NR2B9c (TFA)

CAT: 0804-HY-P0117A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P0117A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS) /PSD-95 interaction, and possesses neuroprotective efficacy[1].
CAS Number
1834571-04-8
Product Name Alternative
Tat-NR2Bct (TFA) ; NA-1 (TFA)
UNSPSC
12352209
Target
IGluR; NO Synthase
Type
Peptides
Related Pathways
Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tat-nr2b9c-tfa.html
Purity
99.66
Solubility
H2O : ≥ 50 mg/mL
Smiles
O=C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC1=CC=C(C=C1)O)N.OC(C(F)(F)F)=O
Molecular Formula
C105H188N42O30.C2HF3O2
Molecular Weight
2632.90
References & Citations
[1]Cui H, et al. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci. 2007 Sep 12;27 (37) :9901-15.|[2]Fan J, et al. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease. Neurobiol Dis. 2012 Mar;45 (3) :999-1009.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
NMDA Receptor; nNOS
Citation 01
Behav Brain Res. 2022 Jan 7:416:113537.|Biochem Biophys Res Commun. 2024 May 8:720:150076.|J Cereb Blood Flow Metab. 2019 Aug;39 (8) :1588-1601. |J Neuropathol Exp Neurol. 2020 Jul 1;79 (7) :800-808.|Neuropharmacology. 2024 Jun 15:251:109905.|Neuroreport. 2021 Sep 8;32 (13) :1122-1127.|PLoS One. 2020 Mar 3;15 (3) :e0229499. |Sci Rep. 2018 May 18;8 (1) :7848.

Related Products

CatalogName
HY-P0117-01Tat-NR2B9c
HY-P5947Tat-HA-NR2B9c
HY-P2307ATat-NR2Baa (TFA)
HY-P0281A-01TAT (TFA)
HY-P10357ATat-CBD3 (TFA)
HY-P1136C-01TAT-Gap19 (TFA)
HY-P1328ATAT-14 (TFA)
HY-P0282A-01TAT peptide (TFA)
HY-P2193ATAT-amide (TFA)
HY-P1575ATAT (48-57) (TFA)

Alternative Products

CatalogName
MBS3847355-01Tat-NR2B9c TFA
A22775-25Tat-NR2B9c TFA 25mg
A22775-1Tat-NR2B9c TFA 1mg
A22775-50Tat-NR2B9c TFA 50mg
A22775-10Tat-NR2B9c TFA 10mg
A22775-5Tat-NR2B9c TFA 5mg
M40591TAT TFA
T76069-01Tat-NR2Baa TFA
T75821-01TAT-Gap19 TFA
GTR19036531-01TAT-14 TFA

Popular Products